Overestimating product reserves as loss of exclusivity (LoE) approaches can be a $75-million mistake
Jeffrey Borman, Integrichain, Inc.
Advertisement
Articles by Jeffrey Borman, Integrichain, Inc.
Advertisement
Latest Updated Articles
- Forecasting Returns When Patents Expire
Published: April 8th 2011 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
US and UK Agree to Zero Tariffs on Pharmaceuticals
2
Pharma Pulse: Medicare Price Cuts and Vaccine Wins
3
How DSCSA Compliance Is Unlocking Recall Efficiency
4
The New Realities of DSCSA Compliance
5
